Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03478163 · ClinicalTrials.gov registry record · Phase 4
Antibiotics During Intrauterine Balloon Tamponade Placement
A Phase 4 study, sponsored by Cedars-Sinai Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT03478163 is a Phase 4 study that was terminated before completion, run by Cedars-Sinai Medical Center. The registered enrollment target is 11 participants.
The verdict
NCT03478163, a Phase 4 study, was terminated before completion, sponsored by Cedars-Sinai Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
The goal of this study is to identify whether antibiotics given at the time of placement of an intrauterine balloon tamponade (IBT) will result in reduction of the risk of endometritis. The investigators hypothesize that antibiotics given at the time of intrauterine balloon tamponade will reduce the likelihood of postpartum endometritis.
Interventions
- DRUG CeFAZolin 1000 MG
- DRUG Clindamycin 900 MG in 6 ML Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-03-08 |
| Est. Completion | 2021-05-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03478163
The ClinicalTrials.gov registry entry for NCT03478163 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CeFAZolin 1000 MG is the first listed.
NCT03478163 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03478163 about?
NCT03478163 is a clinical study titled "Antibiotics During Intrauterine Balloon Tamponade Placement". The goal of this study is to identify whether antibiotics given at the time of placement of an intrauterine balloon tamponade (IBT) will result in reduction of the risk of endometritis. The investigators hypothesize that antibiotics given at the time of intrauterine balloon tamponade will reduce the...
What is the current status of trial NCT03478163?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2018-03-08. Estimated completion is 2021-05-03.
What interventions are being tested in trial NCT03478163?
The interventions under investigation include: CeFAZolin 1000 MG (DRUG), Clindamycin 900 MG in 6 ML Injection (DRUG).
Who is sponsoring clinical trial NCT03478163?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.